Access cutting-edge hiv treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access hiv specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hiv treatment provided free
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this hiv clinical trial in Los Angeles, CA
If you're searching for hiv treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.